About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

9.518 -0.043 (-0.44%)

Streaming Delayed Price Updated: 10:22 AM EST, Dec 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

10 Stocks That Could Rise 10x (Safely) ↗

August 10, 2022

There are two ways to find stocks that could rise 10x. Here are those strategies, and 10 stocks you can buy now to profit.

Via InvestorPlace

AMTD Digital and MEGL Stock: Are Meme Stocks Back? ↗

August 09, 2022

Meteoric rises in HKD stock and MEGL stock have led some to declare a resurgence in meme stocks. Here's how you can profit.

Via InvestorPlace

Cathie Wood Loaded Up on Zymergen (ZY) Stock Before Ginkgo Buyout ↗

July 25, 2022

Zymergen shares are rallying after an all-stock buyout from Ginkgo Bioworks. Cathie Wood's Ark owns both DNA shares and ZY stock.

Via InvestorPlace

Ginkgo Bioworks Expands Horizontal Synthetic Biology Platform With This Stock Deal ↗

July 25, 2022

Via Benzinga

Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock ↗

May 20, 2022

Shares of DNA stock are in focus following Ark Invest's buying spree this month. In the past two days, Ark has purchased 4.5 million shares.

Via InvestorPlace

Losing Money Is in Ginkgo Bioworks Holdings’ DNA ↗

May 19, 2022

DNA stock is a falling knife in 2022, and the latest earnings do not justify being optimistic about reaching profitability soon.

Via InvestorPlace

Zymergen (ZY) Stock Soars 20% on Acquisition News ↗

July 25, 2022

Zymergen finally received some much-needed good news when Ginkgo Bioworks agreed to buy out the firm, sending ZY stock soaring.

Via InvestorPlace

AAPL Stock: When Are Apple Earnings 2022? ↗

July 25, 2022

Investors in Apple (AAPL) stock are anxiously waiting for the company's upcoming earnings report, which is set to take place on Thursday!

Via InvestorPlace

Why Is Ginkgo Bioworks (DNA) Stock in the Spotlight Today? ↗

July 25, 2022

DNA stock is down even while Ginkgo Bioworks prepares to purchase a biotech business and a large research and development site.

Via InvestorPlace

WWE, Infrastructure and Energy Alternatives And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

July 25, 2022

Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) shares rose 26% to $13.14 in pre-market trading. MasTec announced plans to acquire Infrastructure and Energy Alternatives for $14 per share...

Via Benzinga

5 Top Stocks Cathie Wood Bought This Week ↗

July 21, 2022

Shares of ARKK are up about 20% the past month as Cathie Wood continues her highly-convicted purchases of growth stocks.

Via InvestorPlace

7 Stocks Under $10 That Can Double in One Year ↗

July 19, 2022

These seven stocks under $10 have strong fundamentals and can bounce back by 100% from oversold levels in the next 12 months.

Via InvestorPlace

5 Top Stocks Cathie Wood Bought This Week ↗

July 15, 2022

Cathie Wood is still buying the dip and believes that deflationary forces may soon show out. Here are five top stocks she bought this week.

Via InvestorPlace

Cathie Wood Just Doubled Down on Ginkgo Bioworks (DNA) Stock ↗

July 13, 2022

While Ginkgo Bioworks may be a relatively unknown name to many investors, DNA stock is quite well known to Cathie Wood and her Ark funds.

Via InvestorPlace

Futures, Yields, Oil And Gold Slide As German Confidence Plummets To 2011 Lows, Euro Hits Parity ↗

July 12, 2022

US index futures, global markets, Treasury yields, bitcoin and oil all fell on Tuesday as the dollar continued its relentless ascent to levels just shy of the March 2020 global crash record high...

Via Talk Markets

This Healthcare Stock is Surging By Over 21%: Here's 24 Biggest Movers In Tuesday's Pre-Market ↗

July 12, 2022

Gainers Versus Systems Inc. (NASDAQ: VS) rose 66% to $0.7802 in pre-market trading. Versus Systems, last month, received NASDAQ notification regarding minimum bid price deficiency.

Via Benzinga

7 Best Biotech Stocks to Buy in July 2022 ↗

July 08, 2022

The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.

Via InvestorPlace

Billionaire Andreas Halvorsen Just Bought DNA Stock. Here’s Why. ↗

July 07, 2022

DNA stock is surging higher today following large purchases from Viking Global's Andreas Halvorsen and Ark Invest's Cathie Wood.

Via InvestorPlace

Beware These 7 Penny Stock Bubbles Getting Ready to Burst ↗

July 06, 2022

The following penny stocks have built up a large bubble that is yet to burst. They are likely to burst soon due to the market decline.

Via InvestorPlace

Is TSLA Stock Still a Buy? 5 Analysts Weigh In. ↗

July 05, 2022

Tesla (TSLA) stock is a hot topic on Tuesday as analysts react to the company's EV deliveries for the second quarter of 2022.

Via InvestorPlace

Cathie Wood Is Making a Big Bet on Gingko Bioworks (DNA) Stock ↗

July 05, 2022

Cathie Wood's Ark Invest has purchased more than 3.5 million shares of DNA stock since June 29, its first purchases in over a month.

Via InvestorPlace

Why Ginkgo Bioworks Shares Are Rising After Announcement With Partner Cronos Group ↗

June 23, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 7.63% to $2.68 after the company, and Cronos Group Inc (NASDAQ: CRON), announced the achievement of the third target productivity...

Via Benzinga

Cronos Group And Ginkgo Bioworks Achieve Rare Cannabinoid THCV Equity Milestone ↗

June 21, 2022

Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) and Ginkgo Bioworks (NYSE: DNA) achieved the third target productivity milestone in their partnership

Via Benzinga

The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study ↗

June 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Cathie Wood Is Selling Gene Editing Stocks. Here’s Why. ↗

June 02, 2022

Cathie Wood has recently sold off large positions in several gene-editing stocks from her ARKG ETF. What's behind Wood's latest moves?

Via InvestorPlace

74 Biggest Movers From Yesterday ↗

June 03, 2022

Gainers

Via Benzinga

ADSK Stock Sinks 8% Following Analyst Downgrade ↗

May 23, 2022

Autodesk (ADSK) stock is slipping on Monday after getting hit with a downgrade and price target drop from Deutsche Bank analyst Bhavin Shah.

Via InvestorPlace

Benzinga Bulls And Bears Of The Week: Netflix, Coinbase, Apple, Rivian And A Biotech Scooped Up By Cathie Wood ↗

May 21, 2022

Benzinga has examined the prospects for many investor favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro.

Via Benzinga

Tesla Bull Cathie Wood Scoops Up $11.5M In Bill Gates-Backed Biotech's Stock ↗

May 19, 2022

Ark Investment Management, led by Tesla Inc.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022 ↗

May 18, 2022

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Sections

Services

Contact Information

Follow Us